These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 156337

  • 21. Phase II study of combined vincristine, adriamycin, cyclophosphamide, and methotrexate with citrovorum factor factor rescue in metastatic breast cancer.
    Mattsson W, Arwidi A, von Eyben F, Lindholm CE.
    Cancer Treat Rep; 1977 Nov; 61(8):1527-31. PubMed ID: 303543
    [Abstract] [Full Text] [Related]

  • 22. Hormono-chemotherapy versus hormonotherapy followed by chemotherapy in the treatment of disseminated breast cancer.
    Cavalli F, Alberto P, Jungi F, Brunner K, Martz G.
    Eur J Cancer (1965); 1980 Nov; Suppl 1():125-9. PubMed ID: 7032922
    [No Abstract] [Full Text] [Related]

  • 23. Chemotherapy for breast cancer.
    Allegra JC, Lippman ME.
    Compr Ther; 1979 Feb; 5(2):13-7. PubMed ID: 428200
    [Abstract] [Full Text] [Related]

  • 24. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
    Michlmayr G, Kratzer H, Denz H, Huber H.
    Wien Klin Wochenschr; 1981 Mar 20; 93(6):205-7. PubMed ID: 7281697
    [Abstract] [Full Text] [Related]

  • 25. Alternating cyclical hormonal-cytotoxic combination chemotherapy in postmenopausal patients with breast cancer. An EORTC trial.
    Heuson JC, Sylvester R, Engelsman E.
    Eur J Cancer (1965); 1980 Mar 20; Suppl 1():113-7. PubMed ID: 7032920
    [No Abstract] [Full Text] [Related]

  • 26. [Control studies on the cytostatic combination therapy in metastasizing breast carcinoma].
    Brunner KW, Martz G, Senn HJ, Obrecht P, Alberto P, Melchert F.
    Internist (Berl); 1973 Dec 20; 14(12):643-52. PubMed ID: 4593011
    [No Abstract] [Full Text] [Related]

  • 27. Adjuvant oral etoposide plus cisplatin (EoP) following sequential doxorubicin/cyclophosphamide (AC) and docetaxel (T) in early breast cancer patients with 4 or more positive lymph nodes (10 years follow-up).
    Icli F, Akbulut H, Onur H, Yalcin B, Demirkazık A, Senler FÇ.
    Breast; 2011 Apr 20; 20(2):155-7. PubMed ID: 20951586
    [Abstract] [Full Text] [Related]

  • 28. Adjuvant treatment of cancer. II. Breast carcinoma.
    Viola MV, Nystrom JS.
    Conn Med; 1977 Jun 20; 41(6):333-5. PubMed ID: 872584
    [No Abstract] [Full Text] [Related]

  • 29. Oat cell carcinoma of the lung: combination treatment with radiotherapy and cyclophosphamide, adriamycin, vincristine, and methotrexate.
    Wittes RE, Hopfan S, Hilaris B, Golbey RB, Melamed M, Martini N.
    Cancer; 1977 Aug 20; 40(2):653-9. PubMed ID: 196737
    [No Abstract] [Full Text] [Related]

  • 30. Adriamycin in combination for the treatment of breast cancer: a Southwest Oncology Group study.
    Tranum B, Hoogstraten B, Kennedy A, Vaughn CB, Samal B, Thigpen T, Rivkin S, Smith F, Palmer RL, Costanzi J, Tucker WG, Wilson H, Maloney TR.
    Cancer; 1978 Jun 20; 41(6):2078-83. PubMed ID: 657081
    [Abstract] [Full Text] [Related]

  • 31. Calusterone (NSC-88536): a poor substitute for fluoxy-mesterone (NSC-12165) in the treatment of advanced breast cancer.
    Falkson G, van Dyk JJ, van Eden EB, van der Merwe AM, FALKSON HC.
    Cancer Chemother Rep; 1974 Jun 20; 58(6):939-41. PubMed ID: 4615788
    [No Abstract] [Full Text] [Related]

  • 32. Combined chemotherapy and radiotherapy for locally advanced breast cancer.
    Rubens RD, Sexton S, Tong D, Winter PJ, Knight RK, Hayward JL.
    Eur J Cancer (1965); 1980 Mar 20; 16(3):351-6. PubMed ID: 7371690
    [No Abstract] [Full Text] [Related]

  • 33. [Cytostatic combination therapy in metastatic breast cancer].
    Mouridsen HT.
    Ugeskr Laeger; 1973 Jun 18; 135(25):1336-40. PubMed ID: 4757127
    [No Abstract] [Full Text] [Related]

  • 34. Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group.
    Spittle MF, Bates TD, Kitchen G, Nicol NT, Wheeler T, Edelstyn G, MacRae KD, Ostrowski MJ.
    Clin Oncol; 1980 Jun 18; 6(2):153-7. PubMed ID: 7408282
    [No Abstract] [Full Text] [Related]

  • 35. Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapy.
    Nash CH, Jones SE, Moon TE, Davis SL, Salmon SE.
    Cancer; 1980 Dec 01; 46(11):2380-8. PubMed ID: 6449280
    [Abstract] [Full Text] [Related]

  • 36. [Efficacy of doxorubicin (adriamycin) in disseminated forms of breast cancer].
    Trofimova NB, Gorbunova VA.
    Antibiotiki; 1983 Aug 01; 28(8):625-8. PubMed ID: 6638976
    [Abstract] [Full Text] [Related]

  • 37. Adriamycin alone or in combination in 100 patients with carcinoma of the cervix or vagina.
    Piver MS, Barlow JJ, Xynos FP.
    Am J Obstet Gynecol; 1978 Jun 01; 131(3):311-3. PubMed ID: 78671
    [Abstract] [Full Text] [Related]

  • 38. Treatment of metastatic breast cancer with adriamycin-cyclophosphamide induction followed by alternating combination therapy.
    Abeloff MD, Ettinger DS.
    Cancer Treat Rep; 1977 Dec 01; 61(9):1685-9. PubMed ID: 340033
    [Abstract] [Full Text] [Related]

  • 39. [Adjuvant chemotherapy in breast cancer].
    Senn HJ.
    Dtsch Med Wochenschr; 1981 Nov 27; 106(48):1626-30. PubMed ID: 7030686
    [No Abstract] [Full Text] [Related]

  • 40. Adriamycin/cyclophosphamide combination chemotherapy: the importance of drug scheduling.
    Mulder JH, van Putten LM.
    Eur J Cancer (1965); 1979 Dec 27; 15(12):1503-9. PubMed ID: 294960
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.